EUVIMEDEUVIMED entdecken
Crossref

Temporary Mesocaval Shunt: A Surgical Strategy to Facilitate Pancreatic Cancer Resection With Complex Vascular Involvement

Moath Alarabiyat iD, Sarah Powell-Brett, Saad Rehman, Peter Labib iD, Ravi Marudanayagam iD, Bobby Dasari, Syed Soulat Raza iD, David Bartlett, Keith Roberts, Robert Sutcliffe iD, Nikolaos Chatizacharias iD

ANZ Journal of Surgery · 16.09.2026

DOI: 10.1111/ans.70977 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ANZ Journal of Surgery, online erschienen am 16.09.2026. Verfasst von Moath Alarabiyat und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of HPB and Liver Transplant Surgery, Queen Elizabeth Hospital Birmingham, Birmingham, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Extensive vascular involvement remains a major challenge in the surgical management of borderline and locally advanced pancreatic ductal adenocarcinoma (PDAC). Temporary mesocaval shunting (tMCS) may facilitate resection in cases of mesenteric venous occlusion or collateralisation and improve exposure of the superior mesenteric artery; however, its use in pancreatic surgery is rarely reported.

Methods

We performed a retrospective case series of patients with borderline or locally advanced PDAC who underwent curative‐intent resection with intra‐operative tMCS between 2017 and 2022. Demographics, perioperative outcomes, post‐operative complications and survival were analysed using the Kaplan–Meier method.

Results

Six patients underwent pancreatectomy with tMCS (three pancreaticoduodenectomies, three total pancreatectomies). Median age was 58.5 years. All shunts used cryopreserved cadaveric iliac vein grafts. Median length of stay was 13 days. Two patients (33%) developed Clavien–Dindo grade ≥III complications, including one post‐operative death. R0 resection was achieved in two patients (33%). Median overall survival was 24.8 months (33.2 months excluding post‐operative mortality), and median disease‐free survival was 8 months.

Conclusion

Selective tMCS may enable resection in PDAC with extensive vascular involvement. This complex approach should be reserved for carefully selected patients at high‐volume centres with vascular expertise.

Schlagwörter

Stichwörter der Autor:innen

adenocarcinomapancreatic neoplasmspancreaticoduodenectomyportasystemic shuntsurgicalvascular surgical procedures

Autor:innen und Institutionen

  • Department of HPB and Liver Transplant Surgery, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
  • Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

ORCID-Profile: Moath Alarabiyat, Peter Labib, Ravi Marudanayagam, Syed Soulat Raza, Robert Sutcliffe, Nikolaos Chatizacharias

Zitieren

APA

Alarabiyat, M., Powell-Brett, S., Rehman, S., Labib, P., Marudanayagam, R., Dasari, B., Raza, S. S., Bartlett, D., Roberts, K., Sutcliffe, R., & Chatizacharias, N. (2026). Temporary Mesocaval Shunt: A Surgical Strategy to Facilitate Pancreatic Cancer Resection With Complex Vascular Involvement. ANZ Journal of Surgery. https://doi.org/10.1111/ans.70977

Vancouver

Alarabiyat M, Powell-Brett S, Rehman S, Labib P, Marudanayagam R, Dasari B, et al. Temporary Mesocaval Shunt: A Surgical Strategy to Facilitate Pancreatic Cancer Resection With Complex Vascular Involvement. ANZ Journal of Surgery. 2026. doi:10.1111/ans.70977

BibTeX
@article{Alarabiyat2026,
  author = {Alarabiyat, Moath and Powell-Brett, Sarah and Rehman, Saad and Labib, Peter and Marudanayagam, Ravi and Dasari, Bobby and Raza, Syed Soulat and Bartlett, David and Roberts, Keith and Sutcliffe, Robert and Chatizacharias, Nikolaos},
  title = {Temporary Mesocaval Shunt: A Surgical Strategy to Facilitate Pancreatic Cancer Resection With Complex Vascular Involvement},
  journal = {ANZ Journal of Surgery},
  year = {2026},
  doi = {10.1111/ans.70977}
}
Kostenlos starten →